Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s10637-015-0220-z
Published Online: 2015-02-21
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Holstein, Sarah A.
Bigelow, James C.
Olson, Richard D.
Vestal, Robert E.
Walsh, Gerald M.
Hohl, Raymond J.
Text and Data Mining valid from 2015-02-21
Version of Record valid from 2015-02-21
Article History
Received: 9 December 2014
Accepted: 10 February 2015
First Online: 21 February 2015